EFM
MRNA icon

E Fund Management’s Moderna MRNA Stock Holding History

E Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
19,359
+2,122
+12% +$110K 0.03% 184
2026
Q1 		$876K Buy
+17,237
New +$804K 0.03% 203
2025
Q2 		$1.35M Buy
48,865
+10,920
+29% +$288K 0.06% 138
2025
Q1 		$1.08M Buy
37,945
+7,353
+24% +$261K 0.05% 161
2024
Q4 		$1.27M Buy
30,592
+7,939
+35% +$379K 0.06% 134
2024
Q3 		$1.51M Buy
22,653
+9,616
+74% +$883K 0.08% 105
2024
Q2 		$1.55M Buy
13,037
+2,343
+22% +$297K 0.09% 96
2024
Q1 		$1.14M Sell
10,694
-1,604
-13% -$162K 0.07% 105
2023
Q4 		$1.22M Buy
12,298
+3,121
+34% +$263K 0.08% 80
2023
Q3 		$948K Buy
9,177
+1,396
+18% +$156K 0.07% 85
2023
Q2 		$945K Buy
7,781
+235
+3% +$31.3K 0.07% 76
2023
Q1 		$1.16M Buy
7,546
+268
+4% +$44.2K 0.08% 75
2022
Q4 		$1.31M Sell
7,278
-1,662
-19% -$272K 0.11% 73
2022
Q3 		$1.06M Buy
8,940
+237
+3% +$36K 0.1% 86
2022
Q2 		$1.24M Buy
8,703
+1,503
+21% +$215K 0.11% 78
2022
Q1 		$1.24M Buy
7,200
+1,477
+26% +$249K 0.04% 76
2021
Q4 		$1.45M Buy
5,723
+519
+10% +$152K 0.05% 86
2021
Q3 		$2M Buy
+5,204
New +$1.92M 0.08% 65
2021
Q1 		$661K Buy
+5,046
New +$731K 0.05% 113

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

E Fund Management's MRNA Position: Q2 2026 in Review

E Fund Management increased its Moderna (MRNA) stake by 12% in Q2 2026, buying an estimated $110K and bringing the position to 19,359 shares worth $1.36M. The position accounts for 0.03% of the portfolio, ranked #184.

E Fund Management first reported a position in MRNA in Q1 2021 and has held it in 19 quarters since. The position peaked at $2M in Q3 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • E Fund Management held 19,359 shares of Moderna worth $1.36M as of Q2 2026.
  • E Fund Management bought 2,122 Moderna shares in Q2 2026, an estimated $110K.
  • Moderna made up 0.03% of E Fund Management's portfolio in Q2 2026, its #184 holding.
  • E Fund Management first reported a position in Moderna in Q1 2021 and has held it in 19 quarters since.
  • E Fund Management's Moderna position peaked at $2M in Q3 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.